News & Events
Nanopharm News & Events
Nanopharm is continually expanding its specialized nasal and inhaled drug delivery development capabilities and participates in numerous events within the OINDP pharmaceutical community. Learn more about the latest news and events at Nanopharm.
18 July 2025
Aptar Pharma Bolsters Clinical Trial Capabilities with Strategic Materials Manufacturing Acquisition
The acquisition of Mod3 Pharma’s clinical trial materials manufacturing capabilities strengthens Aptar Pharma’s service portfolio to meet growing demand for early-phase clinical trial support and innovation.
Filter Resources By
03 Nov 2021
Aerodynamic, Antigen, Dry Powder, GLA, Human Papillomavirus, Inhalation, Nanopharm, Performance, Vaccine
11 Jan 2021
drug delivery, Inhalation, Low GWP, Nanopharm, pMDIs, Propellants, Valve and Actuator
04 Jan 2021
Container Closure System, Nanopharm, pMDIs, Salmeterol Xinafoate, Valve Types
01 Jan 2021
DPI, drug delivery, Dry powder inhaler, Inhalation, Particle Size, respiratory diseases
09 Jan 2020
DPI, Drug Absorption, Dry powder inhaler, Generic, In Silico, Nanopharm, Tiotropium
08 Jan 2020
Aerodynamic Performance, COPD, FPM, High Resistance, Inhaler, MMAD
07 Jan 2020
Bioequivalent, COPD, DPI, Glycopyrrolate, In Silico, In Vitro, Indacaterol, Nanopharm
02 Jan 2020
DPI, Drug Development, Dry powder inhaler, Fluticasone Propionate, Inhalation
12 Jul 2019
Annealing, DPI, Drug Development, Dry powder inhaler, Micronized, Molecular SFE, Nanopharm
01 Feb 2018
bioequivalence, Drug Development, Formulation, Generic, Nasal, OINDP
